The Healthy Advocate

Pertinent Health Information & Latest Medical News

Smoking May Increase Severity of Coronavirus

2 min read
In patients with coronavirus, smoking may lead to greater disease progression and may increase the risk of more adverse outcomes, a new study suggests.
virus

smoking and coronavirus

Despite the limited data available, research is showing a direct link between smoking and coronavirus progression and severity.

In patients infected by the novel coronavirus (COVID-19), smoking may lead to greater disease progression and may increase the risk of more adverse outcomes, according to a systematic literature review published in Tobacco Induced Diseases.

Is There a Link Between Smoking and Coronavirus Severity?

The COVID-19 virus is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For many people with COVID-19, the most common symptoms include fever, cough, and shortness of breath. Some patients, particularly those with comorbidities, pre-existing medical conditions, or certain risk factors (eg, smoking), may be at an increased risk for more severe symptoms and worse prognosis.

Medical Literature Suggests Smoking May Exacerbate COVID-19

Researchers from the Harvard School of Dental Medicine and the University of Crete in Greece performed a systematic review of the available literature that reported the smoking status of patients with COVID-19. The aim of the study was to assess the association between smoking and coronavirus disease progression.

In this review, a total of 5 retrospective and prospective studies conducted in China — with 4 of these studies conducted in Wuhan — were included for analysis. All 5 studies included in the review covered December 2019 and January 2020, the first 2 months of the COVID-19 pandemic.

Study Findings

A study that included 191 participants found that 9% of patients with COID-19 who smoked had died from complications associated with the virus. This was compared to 4% of patients who died but didn’t smoke. There was no statistical significant difference between the 2 groups (p=0.21).

In another study of 140 patients with COVID-19, a higher proportion of patients with severe disease were current smokers and former smokers (3.4% and 6.9%, respectively). In contrast, 0% and 3.7% of patients with non-severe disease were current smokers and former smokers, respectively (odds ratio [OR], 2.23; 95% CI, 0.65–7.63; p=0.2).

A study of 78 patients with COVID-19 found that those with adverse outcomes were significantly more likely to have a history of smoking compared to the cohort of patients with improvement or stabilization in their disease  (27.3% vs 3.0%, respectively; OR, 14.28; 95% CI, 1.58–25.00; p=0.018).

Limitations

This study was a systematic review of the literature regarding the 2019 to 2020 COVID-19 pandemic. As such, the number of studies for this pandemic is currently sparse. The researchers did not perform a meta-analysis of the data in these 5 studies that reported associations between smoking and coronavirus.

Additionally, while some of the studies included in this review did report a higher proportion of current smokers with greater disease progression and risk of adverse outcomes, the differences between current smokers and non-smokers did not always reach statistical significance. More studies are needed to validate these findings.

Reference:

Vardavas CI, Nikitara K. COVID-19 and smoking: A systematic review of the evidenceTob Induc Dis. 2020;18:20.

Related Posts Plugin for WordPress, Blogger...

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright The Healthy Advocate © 2020 All rights reserved. | Newsphere by AF themes.